P08.60 RAMBO (rapid anti angiogenesis mediated by oncolytic virus) decreased bevacizumab-induced glioma cell invasion

INTRODUCTION: Anti-VEGF therapies such as bevacizumab have been shown to attenuate VEGF-mediated angiogenesis, to decrease vascular permeability, and to inhibit tumor growth in malignant glioma. Conversely, bevacizumab has also been reported to induce invasive proliferation. Oncolytic viral therapy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Tomita, Y., Kurozumi, K., Shimizu, T., Oka, T., Otani, Y., Ishida, J., Fujii, K., Kaur, B., Tomotsugu, I., Date, I.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
POSTER PRESENTATIONS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464039/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.249
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky